Opioid antagonists

15,838views

Opioid antagonists

Neuro

Neuro

Anatomy of the cranial base
Anatomy of the cranial meninges and dural venous sinuses
Anatomy of the ventricular system
Anatomy of the cerebral cortex
Anatomy of the diencephalon
Anatomy of the limbic system
Anatomy of the basal ganglia
Anatomy of the cerebellum
Anatomy of the brainstem
Anatomy of the blood supply to the brain
Anatomy of the ascending spinal cord pathways
Anatomy of the descending spinal cord pathways
Anatomy clinical correlates: Cerebral hemispheres
Anatomy clinical correlates: Vertebral canal
Anatomy clinical correlates: Spinal cord pathways
Development of the nervous system
Central nervous system histology
Peripheral nervous system histology
Neuron action potential
Cerebral circulation
Blood brain barrier
Somatosensory receptors
Sleep
Congenital neurological disorders: Pathology review
Headaches: Pathology review
Seizures: Pathology review
Cerebral vascular disease: Pathology review
Traumatic brain injury: Pathology review
Spinal cord disorders: Pathology review
Dementia: Pathology review
Central nervous system infections: Pathology review
Movement disorders: Pathology review
Demyelinating disorders: Pathology review
Adult brain tumors: Pathology review
Pediatric brain tumors: Pathology review
Neurocutaneous disorders: Pathology review
Anticonvulsants and anxiolytics: Barbiturates
Anticonvulsants and anxiolytics: Benzodiazepines
Nonbenzodiazepine anticonvulsants
Migraine medications
General anesthetics
Local anesthetics
Neuromuscular blockers
Anti-parkinson medications
Medications for neurodegenerative diseases
Opioid agonists, mixed agonist-antagonists and partial agonists
Opioid antagonists
Aqueductal stenosis
Cerebral palsy
Chiari malformation
Dandy-Walker malformation
Spina bifida
Spinocerebellar ataxia (NORD)
Syringomyelia
Introduction to the cranial nerves
Cranial nerve pathways
Anatomy of the olfactory (CN I) and optic (CN II) nerves
Anatomy of the oculomotor (CN III), trochlear (CN IV) and abducens (CN VI) nerves
Anatomy of the trigeminal nerve (CN V)
Anatomy of the facial nerve (CN VII)
Anatomy of the glossopharyngeal nerve (CN IX)
Anatomy of the vagus nerve (CN X)
Anatomy of the spinal accessory (CN XI) and hypoglossal (CN XII) nerves
Anatomy clinical correlates: Glossopharyngeal (CN IX), vagus (X), spinal accessory (CN XI) and hypoglossal (CN XII) nerves
Anatomy of the white matter tracts
Anatomy and physiology of the ear
Auditory transduction and pathways
Vestibular transduction
Eustachian tube dysfunction
Acoustic neuroma (schwannoma)
Vertigo: Pathology review
Dizziness and vertigo: Clinical
Normal pressure hydrocephalus
Migraine
Ascending and descending spinal tracts
Brown-Sequard Syndrome
Cauda equina syndrome
Friedreich ataxia
Seizures and epilepsy
Febrile seizure
Anatomy and physiology of the eye
Optic pathways and visual fields
Eye and ear histology
Anatomy of the orbit
Photoreception
Vestibulo-ocular reflex and nystagmus
Anatomy of the eye
Glaucoma
Eye conditions: Retinal disorders: Pathology review
Eye conditions: Inflammation, infections and trauma: Pathology review
Eye conditions: Refractive errors, lens disorders and glaucoma: Pathology review
Nasal, oral and pharyngeal diseases: Pathology review
Basal ganglia: Direct and indirect pathway of movement
Huntington disease
Parkinson disease
Mood disorders: Pathology review
Trauma- and stress-related disorders: Pathology review
Amnesia, dissociative disorders and delirium: Pathology review
Schizophrenia spectrum disorders: Pathology review
Personality disorders: Pathology review
Malingering, factitious disorders and somatoform disorders: Pathology review
Eating disorders: Pathology review
Psychological sleep disorders: Pathology review
Developmental and learning disorders: Pathology review
Childhood and early-onset psychological disorders: Pathology review
Psychiatric emergencies: Pathology review
Drug misuse, intoxication and withdrawal: Stimulants: Pathology review
Drug misuse, intoxication and withdrawal: Alcohol: Pathology review
Drug misuse, intoxication and withdrawal: Hallucinogens: Pathology review
Selective serotonin reuptake inhibitors
Serotonin and norepinephrine reuptake inhibitors
Tricyclic antidepressants
Monoamine oxidase inhibitors
Atypical antidepressants
Typical antipsychotics
Atypical antipsychotics
Lithium
Psychomotor stimulants
Frontotemporal dementia
Dementia and delirium: Clinical

Transcript

Watch video only

Opioid antagonists, like the name suggests, are medications that block opioid receptors. They’re used mainly to urgently reverse the side effects of opioid agonists and to help individuals who are recovering from opioid use disorder.

Now, opioids work by binding to opioid receptors in the brain, spinal cord, and gastrointestinal tract. Some are endogenous, meaning they are produced naturally by the body, like endorphins, named for “endogenous morphine” due to their similar effects in the body. But others are exogenous, meaning they come from outside the body, like heroin and morphine, which come from the opium poppy; a flowering plant that oozes a milky white liquid.

To understand how opioids work, let’s zoom in on a region of the spinal cord that has opioid receptors. Normally, in the absence of endorphins, nociceptive fibers carry pain signals from the body to the dorsal, or posterior, horn of the spinal cord, where they release neurotransmitters like glutamate, substance P and calcitonin gene-related peptide. These neurotransmitters cause pain signals to be transmitted to the brain via ascending pain pathways.

Now, let’s say someone goes to play a rigorous game of badminton. Exercise releases endorphins which activate the three major opioid receptors located on neurons, called the mu, kappa, and delta receptors. As endorphins or other opioids bind to these receptors on the presynaptic terminals of nociceptive fibers, they inhibit the opening of calcium channels, preventing calcium influx, and thereby blocking the release of pain-causing neurotransmitters like glutamate, substance P and calcitonin gene-related peptide. At the same time, endorphins also bind to postsynaptic neurons, opening potassium channels here, leading to hyperpolarization and decreased excitability of the neuron. These effects together reduce the transmission of pain signals to the brain.

Now, opioids also have action on the body’s dopaminergic, noradrenergic, and serotonergic pathways.

In the brain’s reward pathway, located in the midbrain, opioids bind to receptors on inhibitory GABAergic neurons, causing a decrease in the release of gamma-aminobutyric acid, also known as GABA. This, in turn, leads to less inhibition of dopaminergic neurons and therefore more dopamine. This increase in dopamine is why opioids cause feelings of pleasure or euphoria.

For the noradrenergic effects, opioids inhibit noradrenergic neurons in the brain, especially in the locus coeruleus, leading to a decrease in norepinephrine release. This contributes to the sedative effects of opioids.

Last, certain opioids activate neurons that release serotonin in the spinal cord, helping to reduce pain transmission.

Now that we’ve covered how opioids work, let's talk more about some of the unwanted effects. There are opioid receptors throughout our body, like in the gastrointestinal tract. So, when a person receives a dose of morphine, it could also result in a series of unwanted side effects, like nausea, vomiting, and constipation.

Other side effects of opioids include pupillary constriction as well as flushing.

However, the most dangerous side effect is respiratory depression, caused by decreased activity in the medulla; the part of the brain that regulates breathing. This happens when a person overdoses on an opioid, like morphine, fentanyl, or heroin.

Respiratory depression can be life-threatening and should be treated right away - because the person can literally stop breathing.

Also, watch out for central nervous system depression, which can lead to coma, and cardiac problems like bradycardia and other arrhythmias.

Now in order to treat opioid overdoses, we can use an opioid antagonist like naloxone. Naltrexone on the other hand, is a medication that is helpful as maintenance therapy in opioid use disorder and alcohol use disorder. Other opioid antagonists like methylnaltrexone and alvimopan can help counteract opioid-induced constipation. These medications all bind strongly to opioid receptors without activating them.

Since naloxone has a higher affinity for opioid receptors than opioid agonists like morphine, fentanyl and heroin do, it actually displaces the agonist from the receptor and doesn’t allow another to bind. Naloxone readily crosses the blood-brain barrier and has a rapid onset and short duration of action of 1 to 2 hours.

So, when it’s given intravenously or intranasally, it can reverse the central effects of opioids within minutes, potentially saving a person’s life.

Another potential use of naloxone, is to detect when a person is physically dependent on opioids. Although not commonly done, this can sometimes be useful before starting a long-acting medication like naltrexone to help manage opioid use disorder.

Key Takeaways

Opioid antagonists are drugs that strongly bind to opioid receptors and prevent their activation. They are used to treat opioid overdose and addiction, and can also help to reverse respiratory depression and other adverse effects of opioids. Examples include drugs like naloxone, naltrexone, methylnaltrexone, and alvimopan.

Sources

  1. "Katzung & Trevor's Pharmacology Examination and Board Review,12th Edition" McGraw-Hill Education / Medical (2018)
  2. "Rang and Dale's Pharmacology" Elsevier (2019)
  3. "Goodman and Gilman's The Pharmacological Basis of Therapeutics, 13th Edition" McGraw-Hill Education / Medical (2017)
  4. "Naloxone treatment in opioid addiction: the risks and benefits" Expert Opin Drug Saf (2007)
  5. "Methylnaltrexone" Drugs (2010)
  6. "Naltrexone: A Pan-Addiction Treatment?" CNS Drugs (2016)
  7. "Approach to buprenorphine use for opioid withdrawal treatment in the emergency setting" The American Journal of Emergency Medicine (2019)